What is Workplace Giving?

Workplace Giving is a simple and effective way to donate to charities directly from your pay. The Good2Give Workplace Giving Platform is an easy and secure way to give a regular or one-time donation directly to charities that matter to you.

Nominate your Workplace

* We are constantly adding new organisations to this list.
If your employer isn't listed here yet, please donate
via another payment method

Help Rick Worthington reach their target

Donations big & small make a difference

Donate Now

Donate now using your credit card or PayPal account using our secure payment gateway and recieve a tax deductible receipt emailed directly to you

Donate via Workplace Giving powered by Good2Give

Donate directly from your salary and avoid needing to claim at tax time. Workplace giving is powered by Good2Give. Your employer must be registered with Good2Give to use Workplace Giving.

 saving changes, please wait..

 page successfully updated

 error saving changes

 file size exceeds 512kb.

AUD $919 of AUD $3,500 target.

Don't see the secure browser? We'll help you re-launch the window to complete your connection.

continue close

Rick Worthington

$919 of AUD $3,500 target.

Raised by 0 people in days for Melanoma Institute Australia

Biggest Supporters

AUD $265.00

Courtney Bailey

AUD $106.00

Annie Hird

Rick Worthington - Great Wall of China Trek 2017


In September 2017 I will be participating in an 11-day trek along the Great Wall of China to raise funds for the Melanoma Institute Australia (MIA).

Every dollar raised through the Great Wall of China Trek will go towards supporting the continual work of MIA, providing much needed funds for life-saving research. By taking part in this amazing adventure I will be raising vital funds to bring MIA ever closer to finding a cure for melanoma.

MIA is a not-for-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs. MIA relies on the generosity of individuals, organisations and government funding to continue its ground breaking work into Australia’s national cancer which is the most common cancer in young Australians aged 15–39 years.

Where does my fundraising go?

NeoTrioTrial: prevent melanoma advancing

As the saying goes, 'prevention is the best cure, and MIA's Neo Trio Trial is all about this.

The standard treatment for patients who develop stage III melanoma (melanoma which has travelled to the lymph nodes) is to have surgery to remove the affected and surrounding lymph nodes, known as a complete lymph node dissection.

Sadly, even after this proceedure, there is high likelihood of the melanoma returning and advancing to stage IV melanoma, meaning it has spread to distant organs around the body causing it to be highly life threatening.

New drugs have been trialled and shown to be effective to treat stage IV melanoma, but wouldn't it be incredible if we could stop it advancing to this point in the first place?

The Neo Trio Trial is an important clinical study that will test whether immunotherapy treatments currently used to treat stage IV patients could in fact prevent patients from developing advanced melanoma all together.

On the trial, patients with stage III melanoma will receive immunotherapy or immunotherapy plus targeted therapy before and after their complete lymph node dissection to see if it will prevent stage IV melanoma from developing.  This will be evolutionary if it works.

read more




All Donations 0 Activity 0


There is nothing to show from any feeds at the moment.


There are no current donations or activities for this user.


The fitness feed has been disabled by the page owner.

Melanoma Institute Australia

Melanoma Institute Australia is dedicated to preventing and curing melanoma through world-class research, treatment and education programs. 

Australia has one of the highest incidences of melanoma in the world, and melanoma is often referred to as ‘Australia’s national cancer’. Over 14,000 new cases are diagnosed each year. More than 1,800 Australians are expected to die from melanoma each year. Melanoma is the most common cancer in young Australians aged 15-39 and kills more young Australians than any other single cancer.  

The good news is that Australia is also leading the world in the fight against melanoma with recent research tripling the life expectancy for some advanced melanoma patients. 

However, many patients are not responding to new treatments and further research is needed. Your support will raise money for vital melanoma research and contribute to our education programs. 

To find out more please visit http://melanoma.org.au

read more

Created by

Rick Worthington

for Melanoma Institute Australia

Fundraising for

is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

read more

Recent Supporters

AUD $919 of AUD$3,500 target

0 people in days